Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Aoba-ku, Miyagi, Japan.
Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
J Intensive Care Med. 2020 May;35(5):502-510. doi: 10.1177/0885066618761637. Epub 2018 Mar 15.
Although the quick Sequential Organ Failure Assessment (qSOFA) has been recommended for identifying patients at higher risk of hospital death, it has only a 60% sensitivity for in-hospital mortality. On the other hand, hypothermia associates with increased mortality and organ failure in patients with sepsis. This study aimed to assess the predictive validity of qSOFA for identifying patients with sepsis at higher risk of multiple organ dysfunction or death and the complementary effect of hypothermia.
Patients with severe sepsis admitted to intensive care units (ICUs) were retrospectively analyzed. The predictive validities of qSOFA (≥2, positive) and the complementary effect of hypothermia (body temperature ≤36.5°C) for the identification of death or multiorgan dysfunction were evaluated.
Of the 624 patients, 230 (36.9%) developed multiorgan dysfunction and 144 (23.1%) died within 28 days; 527 (84.5%) had a positive qSOFA. The 28-day mortality rates of patients with positive and negative qSOFA were 25.4% and 10.3%, respectively ( = .001). The rate of positive qSOFA was higher in patients with multiorgan dysfunction (sensitivity, 0.896; specificity, 0.185) and among patients who died within 28 days (sensitivity, 0.931; specificity, 0.181); 10 (6.9%) of 144 deaths were not identified. In cases of positive qSOFA without hypothermia, positive qSOFA + hypothermia, or negative qSOFA with hypothermia, the predictive value for 28-day mortality improved (sensitivity, 0.979). Among the 144 patients who died, only 3 were not identified.
A qSOFA score ≥2 may identify >90% of 28-day deaths among patients with severe sepsis; hypothermia may complement the predictive ability of qSOFA.
虽然快速序贯器官衰竭评估(qSOFA)已被推荐用于识别具有更高住院死亡风险的患者,但它对住院死亡率的敏感性仅为 60%。另一方面,低温与脓毒症患者的死亡率和器官衰竭增加有关。本研究旨在评估 qSOFA 对识别具有更高多器官功能障碍或死亡风险的脓毒症患者的预测有效性,以及低温的补充作用。
回顾性分析入住重症监护病房(ICU)的严重脓毒症患者。评估 qSOFA(≥2,阳性)和低温(体温≤36.5°C)对识别死亡或多器官功能障碍的预测有效性。
在 624 名患者中,230 名(36.9%)发生多器官功能障碍,144 名(23.1%)在 28 天内死亡;527 名(84.5%)有阳性 qSOFA。阳性和阴性 qSOFA 患者的 28 天死亡率分别为 25.4%和 10.3%(=.001)。多器官功能障碍患者的 qSOFA 阳性率较高(敏感性为 0.896;特异性为 0.185),28 天内死亡的患者阳性率也较高(敏感性为 0.931;特异性为 0.181);144 例死亡中有 10 例(6.9%)未被识别。在 qSOFA 阳性而无低温、qSOFA+低温或 qSOFA 阴性而有低温的情况下,28 天死亡率的预测值提高(敏感性为 0.979)。在 144 名死亡患者中,仅 3 例未被识别。
qSOFA 评分≥2 可识别 90%以上的严重脓毒症患者 28 天内的死亡;低温可能补充 qSOFA 的预测能力。